Cargando…

COVID-19 associated mucormycosis, host-iron assimilation: Probiotics can be a novel therapy

Detalles Bibliográficos
Autores principales:	Bhardwaj, Ankit, Roy, Vandana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641750/ https://www.ncbi.nlm.nih.gov/pubmed/34854413 http://dx.doi.org/10.4103/ijp.ijp_406_21

Ejemplares similares

A toddler infected with mucormycosis – reporting the youngest case of mucormycosis in post COVID phase
por: Kubre, Jyotsna, et al.
Publicado: (2023)

Mucormycosis in COVID-19: The Indian scenario
por: Ghosh, Ritwik, et al.
Publicado: (2022)

COVID-19 and orbital mucormycosis
por: Sarkar, Sandip, et al.
Publicado: (2021)

The surge in Covid related mucormycosis
por: Chandra, Somesh, et al.
Publicado: (2021)

Prevention of mucormycosis in COVID-19 – the need of the hour
por: Ish, Pranav, et al.
Publicado: (2021)

Triple challenge of diabetes, COVID-19, and mucormycosis
por: Rastogi, Ashu, et al.
Publicado: (2021)

Mucormycosis Following COVID-19 Infections: an Insight
por: Das, Srijit, et al.
Publicado: (2021)

Mucormycosis: A killer in the shadow of COVID-19
por: Suvvari, Tarun Kumar, et al.
Publicado: (2021)

Mitigating the Emerging Threat of Mucormycosis in COVID-19
por: Pothiawala, Sohil
Publicado: (2021)

COVID-19 and Rhino-Cerebral Mucormycosis: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Additional insights on COVID-associated mucormycosis
por: Panta, Prashanth
Publicado: (2022)

Comments on: Rise of the phoenix: Mucormycosis in COVID-19 times
por: Singh, Awadhesh K, et al.
Publicado: (2021)

Mucormycosis—A serious threat in the COVID-19 pandemic?
por: Szarpak, Lukasz, et al.
Publicado: (2021)

Should statins be considered for the management of mucormycosis in COVID-19?
por: Chatterjee, Subhankar, et al.
Publicado: (2021)

COVID-19 associated mucormycosis - a recent challenge
por: dos Santos, Vitorino Modesto, et al.
Publicado: (2023)

COVID-19, steroids, and mucormycosis: What an ophthalmologist should know
por: Tandon, Abhishek, et al.
Publicado: (2021)

Response to comments on: Rise of the phoenix: Mucormycosis in COVID-19 times
por: Ravani, Swati A, et al.
Publicado: (2021)

Mucormycosis in COVID-19: Is Zinc a Silent Killer in India?
por: Nath, Sayan, et al.
Publicado: (2021)

COVID 19 infection and mucormycosis—a dangerously increasing combination
por: Bakshi, Satvinder Singh, et al.
Publicado: (2021)

Concurrent plexiform ameloblastoma and COVID-19-associated mucormycosis of the maxilla
por: Ingle, Yashwant, et al.
Publicado: (2022)

COVID-19-Associated Mucormycosis in Diabetic Patients: The Tip of an Iceberg
por: Parsaei, Amirhossein, et al.
Publicado: (2022)

Rhino-Orbito-Cerebral Mucormycosis (ROCM) in COVID-19 Patients
por: Sharma, Vagisha, et al.
Publicado: (2023)

Preliminary Planning for Mucormycosis in Developing Countries During COVID-19 Pandemic
por: Shakrawal, Neha, et al.
Publicado: (2021)

COVID-19 associated mucormycosis (CAM): A tale of two pathogens
por: Pustake, Manas, et al.
Publicado: (2021)

Comment to: “Association of COVID-19 with Rhino-Cerebral Mucormycosis: An Observational Study”
por: Vaidyanathan, Aiswarya, et al.
Publicado: (2022)

Be vigilant in treating a patient with diabetes and COVID-19-associated mucormycosis
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2023)

Post-COVID mucormycosis: Ascertainment of the pathological diagnostic approach
por: Sood, Anubhuti, et al.
Publicado: (2021)

Does Long-term Oxygen Therapy and Noninvasive Ventilation Predispose Rhino-orbital-cerebral Mucormycosis in COVID-19 Patients?
por: Kumar, Amarjeet, et al.
Publicado: (2022)

Pathogenesis of COVID-19-associated mucormycosis (CAM) in India: probing the triggering factors
por: Arakeri, Gururaj, et al.
Publicado: (2022)

COVID-19 Associated Mucormycosis and Anbarnesa: Concerning about Important Source of Spores
por: Pourazizi, Mohsen, et al.
Publicado: (2022)

COVID-19 Associated Mucormycosis: Ramping up our services during crisis
por: Xess, Immaculata, et al.
Publicado: (2022)

Palliative oral care for COVID-19 associated oral mucormycosis in diabetic patients
por: Rathee, Manu, et al.
Publicado: (2022)

COVID-associated mucormycosis (CAM): is the Delta variant a cause?
por: Arakeri, Gururaj, et al.
Publicado: (2022)

Expression Patterns in Reductive Iron Assimilation and Functional Consequences during Phagocytosis of Lichtheimia corymbifera, an Emerging Cause of Mucormycosis
por: Stanford, Felicia Adelina, et al.
Publicado: (2021)

Mucormycosis masquerading as an endobronchial tumor
por: Mahajan, Rajesh, et al.
Publicado: (2014)

Can iron chelation as an adjunct treatment of COVID-19 improve the clinical outcome?
por: Abobaker, Anis
Publicado: (2020)

Role of Face Masks in the Rise of Mucormycosis Cases in India during the COVID-19 Pandemic
por: Chandan, SN
Publicado: (2021)

Post COVID-19 mucormycosis in liver transplant recipients-Walking on a tight rope
por: Jadaun, Shekhar Singh, et al.
Publicado: (2021)

Probiotics for the Prevention of COVID-19 Sequelae
por: KOW, CHIA SIANG, et al.
Publicado: (2022)

Gastrointestinal mucormycosis post lung transplantation
por: Reis, Flavio Pola dos, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_u28dbqfdhg65mia9t6rh9n0l0a